Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 251 entries
View as:

Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01074294 Org: User:
Start: 03/16/10 End: 06/20/11 Due: 06/20/12

A Proof-of-concept Trial for OPC 131461 in Patients Hospitalized for Worsening Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT06795399 Org: User:
Start: 04/30/25 End: 01/31/27 Due: 01/31/28

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole

Phase: N/A Priority: Normal
NCT ID: NCT01432444 Org: User:
Start: 09/30/11 End: 12/31/13 Due: 12/31/14

Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT02013622 Org: User:
Start: 11/30/13 End: 10/31/14 Due: 10/31/15

A Study to Evaluate the Efficacy, Safety and Tolerability of SEP-363856 in Subjects With Parkinson's Disease Psychosis

Phase: N/A Priority: Normal
NCT ID: NCT02969369 Org: User:
Start: 12/31/16 End: 04/20/20 Due: 04/20/21

A Study to Evaluate the Long-Term Safety and Efficacy of JNT-517 in Participants With Phenylketonuria

Phase: N/A Priority: Normal
NCT ID: NCT06628128 Org: User:
Start: 06/30/25 End: 02/29/28 Due: 02/28/29

A Phase 2 Study of JNT-517 in Adolescent Participants With Phenylketonuria

Phase: N/A Priority: Normal
NCT ID: NCT06637514 Org: User:
Start: 07/31/25 End: 02/28/26 Due: 02/28/27

Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01393613 Org: User:
Start: 07/31/11 End: 02/28/14 Due: 02/28/15

Assessment of the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Phase: N/A Priority: Normal
NCT ID: NCT04408755 Org: User:
Start: 07/13/20 End: 06/27/24 Due: 06/27/25

An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01646827 Org: User:
Start: 05/31/12 End: 04/30/13 Due: 04/30/14

A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)

Phase: N/A Priority: Normal
NCT ID: NCT02009878 Org: User:
Start: 11/30/13 End: 06/30/15 Due: 06/30/16

Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00095524 Org: User:
Start: 03/31/04 End: 08/31/06 Due: 08/31/07

Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT03896945 Org: User:
Start: 02/15/19 End: 05/23/23 Due: 05/23/24

To Assess the Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

Phase: N/A Priority: Normal
NCT ID: NCT01123707 Org: User:
Start: 11/18/10 End: 09/27/11 Due: 09/27/12

Retrospective Database Study of Real World Abilify Outcomes in Major Depressive Disorder (MDD)

Phase: N/A Priority: Normal
NCT ID: NCT01284218 Org: User:
Start: 01/31/11 End: 12/31/11 Due: 12/31/12

Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01423916 Org: User:
Start: 07/31/11 End: 03/31/12 Due: 03/31/13

Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure Patients

Phase: N/A Priority: Normal
NCT ID: NCT00043771 Org: User:
Start: 05/31/02 End: 09/30/02 Due: 09/30/03

Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Participants With Dementia of the Alzheimer's Type

Phase: N/A Priority: Normal
NCT ID: NCT02442778 Org: User:
Start: 11/11/15 End: 09/09/19 Due: 09/09/20

Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00705783 Org: User:
Start: 07/31/08 End: 02/28/11 Due: 02/28/12

"SALT Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia

Phase: N/A Priority: Normal
NCT ID: NCT00072683 Org: User:
Start: 04/30/03 End: 02/28/06 Due: 02/28/07

Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Phase: N/A Priority: Normal
NCT ID: NCT04464564 Org: User:
Start: 09/11/20 End: 06/28/24 Due: 06/28/25

A Phase 1 Study to Investigate the Safety, Tolerance, Food Effect, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of Extended Release Formulations of Centanafadine (CTN) in Young Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02827513 Org: User:
Start: 12/31/15 End: 01/31/16 Due: 01/31/17

A Study to Evaluate the Safety and Efficacy of JNT-517 in Participants With Phenylketonuria (PKU)

Phase: N/A Priority: Normal
NCT ID: NCT06971731 Org: User:
Start: 08/31/25 End: 10/31/27 Due: 10/31/28

Safety and Tolerability Trial of Aripiprazole IM Depot Treatment in Adult Subjects With Schizophrenia Stabilized on Oral Antipsychotics Other Than Aripiprazole

Phase: N/A Priority: Normal
NCT ID: NCT01552772 Org: User:
Start: 01/31/12 End: 04/30/12 Due: 04/30/13

Study of Aripiprazole in Subjects With Alcoholism

Phase: N/A Priority: Normal
NCT ID: NCT00082199 Org: User:
Start: 04/30/04 End: 08/31/05 Due: 08/31/06